Post Profile

From CARTs To Checkpoints, Here's What's Coming In Immuno-Oncology

Kite Pharma is soaring on positive trial results of its engineered T-cells for fighting cancer, but there are plenty of hurdles ahead for everyone working in the nascent field of immuno-oncology.
read more


Related Posts

Synta Announces Ganetespib Phase 2 Non-Small Cell Lung Cancer Trial Results Show Encouraging Single Agent Clinical Activity

Health : Medical News Today

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung c...

Merck Serono announces results of the Phase III start trial investigating Tecemotide in non-small cell lung cancer

Health : Medical News Today

Merck Serono, the biopharmaceutical division of Merck, has announced that The Lancet Oncology has published results from the Phase III trial of its investigational MUC1 antigen specific cancer immunotherapy tecemotide (also known as...

Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells

Health : Newswise Medical News

At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discover...

ACORN Research Reports Positive Findings Of Phase 2b Metastatic Breast Cancer Trial At ASCO

Health : Medical News Today

Accelerated Community Oncology Research Network, Inc., (ACORN), reported positive results of a large double-blind, randomized Phase 2b trial in patients with breast cancer at the American Society of Clinical Oncology (ASCO) 47th ann...

Afatinib shows benefits for EGFR mutation positive non-small cell lung cancer patients across various efficacy endpoints

Health : Medical News Today

Data from the LUX-Lung clinical trial programme, investigating afatinib in patients with advanced non-small cell lung cancer (NSCLC), have been published in the Journal of Clinical Oncology. These data include results from the pivot...


Copyright © 2016 Regator, LLC